Skip to Content

DPI 894 (Guaifenesin and pseudoephedrine 250 mg / 120 mg)

Pill imprint DPI 894 has been identified as Guaifenesin and pseudoephedrine 250 mg / 120 mg.

Guaifenesin/pseudoephedrine is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/pseudoephedrine 250 mg / 120 mg is not a controlled substance under the Controlled Substance Act (CSA).

Guaifenesin and pseudoephedrine 250 mg / 120 mg DPI 894 Front
Guaifenesin and pseudoephedrine 250 mg / 120 mg DPI 894 Back
Discount Card Promo
Guaifenesin and pseudoephedrine
Imprint:
DPI 894
Strength:
250 mg / 120 mg
Color:
White / Clear
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Duramed Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide